Todd D. Sonoga

GenBio Inc. is a US-based biotechnology company that undertakes specialized phytochemical research into uniquely globally sourced and very rare novel natural extracts both in the USA and overseas to determine the bioavailability, medicinal properties, phytochemistry and therapeutic mechanisms of natural ingredients as they relate to human health. Current research focuses on the evaluation of health-promoting phytochemicals, including major hydrophilic and lipophilic compounds and their respective antioxidant capacities. We use the latest scientific equipment, including LC/MS and NMR technology. The Company utilizes these new drug discoveries for further ongoing design, synthesis, preclinical testing, and manufacturing scale-up to GLP standards from a selection of its appropriate novel lead compounds for their corporate clients, especially in the food and nutraceutical channel. Working iteratively and in close co-operation with our partners, our rational approach to molecular modeling to optimize drug candidates based on our core scaffolds can lead to spectacular new treatment modalities for natural medicines, based on cost-effective strategies. There is a large market gap for new novel ingredients, backed by credible science, either as a stand-alone or “infused”, in other words, to be added to the existing current nutraceutical, pharmaceutical, and food brands to increase and promote wellness and human health. We can give companies a powerful competitive edge. Through reformulation, new improved formulas become a reality. The company has an extensive library of phytochemical footprints and cutting-edge research. All our formulations and backed by science and research, some carried out in the USA.